Strong close today at $4.60, after several green days and gradually increasing volume.
Nice trend. With MAPS FDA submission made, Clarion ethics approval in recent news, final PsiGAD phase 2 readouts around the corner, AND the entire biotech sector showing new signs of life... I'd say we might be off to a good start in 2024.